Category Archives: Stocks

MRI Interventions Reports 52% Increase in First Quarter Revenue

MRI Interventions logo

Record $2.5 million quarterly revenue driven by growth across entire portfolio OTCQB: MRIC) (the “Company”) today announced financial results for its first fiscal quarter ended March 31, 2019.

First Quarter 2019 Highlights

  • Increased first quarter revenue 52% year-over-year to $2.5 million.
  • Reported $1.6 million in quarterly functional neurosurgery revenue, an increase of 38% over the prior year first quarter.
  • Reported biologics and drug delivery revenue of $382,000, an increase of 93% over the prior year, including first European shipments to Lysogene for use in their P4-SAF-302 trial.
  • Reported capital sales and other services revenue of $486,000, which includes two system sales; the systems sales, combined with three evaluation installations, bring total U.S. installed base to 63 systems.
  • Completed 175 procedures across the Company’s product portfolio.
  • Completed the transfer of the V-Tag 510(k) from Voyager Therapeutics, Inc. and completed initial clinical builds.
  • Generated gross margin of 64%.
  • Maintained reduction of cash used in operations to $609,000, which included annual bonus compensation and semi-annual interest payment.

Resurrection of Emergent Health Corp. (EMGE: OTC Markets)

JDI Life logo

Emergent Health Corp. (the “Company”) purpose is to update shareholders:

  1. The Company had a loss of $900,000 under a FL management team from 2015 to early 2017. This has now become a loss carry forward.
  2. New management has taken control of the Company and revenue and a small profit was produced in 2018. Though the results may be considered nominal at this time, it is believed to be a snapshot of the future.
  3. The Company has the intention to become a holding company and build value on the basis of Book Value, profit and rate of growth.
  4. The Company is in process of launching a network marketing division http://jdi.jdilife.com The plan is to build this division to the point of supporting it as a public company subsidiary of the Company.
  5. The Company intends to form a Medical Food company, which it too intends to have become a public company subsidiary of the Company. The intended initial product has Intellectual Property protection.
  6. The company intends to diligently work towards current status on OTC Markets.
  7. From time to time, management on behalf of the Company, may purchase Company shares in the open market with the intention to retire those shares to the Company Treasury.

MTrac Emerging as the FinTech Provider of Choice is Poised for Exponential Revenue Growth in 2019

Global-Payout-logo

Global Payout Inc. (OTCPINK: GOHE) (“Global”) and its wholly-owned subsidiary MTrac Tech Corporation (“MTrac”) are pleased to announce that transactional data and revenue into Q1 of 2019 highlights the continued growth, adaptation, and overall benefit to the one-of-kind MTrac Payment Solution.

As has been the trend since the current iteration of the MTrac system was deployed back in October, totals associated with daily and monthly sales and transactional volume along with the average ticket cost processed within the system continue to climb each month at what the Company perceives to be a very steady and encouraging pace, and the first quarter is seeing a continuation of this very positive trend. 

OTC Markets Lists Securities of Fuse Medical, Inc. as Exempt from Penny Stock Designation

Fuse Medical logo

Fuse Medical, Inc., (OTC PINK: FZMD), (“Fuse” or the “Company”), announced that OTC Markets has identified Fuse as “Penny Stock Exempt,” meaning that shares of Fuse’s common stock, par value $0.01 per share (the “Common Stock”), is no longer a “Penny Stock” as defined in Rule 3a51-1, promulgated under the Securities Exchange Act of 1934, as amended.

To qualify as “Penny Stock Exempt” on the OTC Markets, an issuer must satisfy one of the following requirements: (i) the issuer’s securities have a minimum price greater than $5 per share; (ii) the issuer has average revenues of at least $6 million for the last three (3) years; or (iii) the issuer has net tangible assets exceeding $2 million, if the issuer has been in continuous operations for at least three (3) years or $5 million if less than three (3) years.

Mikros Systems Announces 2014 Results: Record Profits and Backlog

Revenues Up 80%; Backlog at $5.5M; ADEPT Contract Extended Through August 2016

PRINCETON, N.J., March 31, 2015 (GLOBE NEWSWIRE) — Mikros Systems Corporation (MKRS), an advanced technology company which designs and manufactures specialized electronic systems for the Department of Defense, today announced strong financial results for 2014, including record profits for the year and the largest backlog for future orders in the Company’s history.

Mikros reported revenues of $5.53 million in 2014, compared to $3.05 million in 2013, an increase of $2.48 million or more than 80%. Net income was $533,000 compared to a loss of $147,000 in 2013. As of December 31, 2014, the backlog for future orders stood at $5.5 million, representing the highest backlog in the history of the Company.

“We are delighted to report a return to profitability after surviving a lean 2013 caused primarily by defense budget sequestration cuts and delays,” said Mikros President Tom Meaney. “Not only did Mikros come back with strong operating performance in 2014, we also generated multiple new contracts and task orders under existing contracts and believe our prospects for future growth are as strong as they have ever been. We continue to receive orders for additional production and related support of our ADEPT products, and several important new development contracts which will extend the system to maintain other Navy radars and combat system equipment.”